[Research progress of ellagitannin intestinal metabolite urolithins].

Zhou, Ben-Hong; Qiu, Zhen-Peng; Yi, Hui-Lan; Zhou, Ding-Shan; Wang, Jing; Wu, Yue

Zhou, Ben-Hong; Qiu, Zhen-Peng; Yi, Hui-Lan; Zhou, Ding-Shan; Wang, Jing; Wu, Yue.

Affiliation

Zhou BH; Renmin Hospital of Wuhan University, Wuhan 430060, China.
Qiu ZP; Key Laboratory of Traditional Chinese Medicine Resources and Traditional Chinese Medicine Compounds, Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, China.
Yi HL; Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zhou DS; Renmin Hospital of Wuhan University, Wuhan 430060, China.
Wang J; Renmin Hospital of Wuhan University, Wuhan 430060, China.
Wu Y; Renmin Hospital of Wuhan University, Wuhan 430060, China.

Zhongguo Zhong Yao Za Zhi ; 41(16): 2968-2974, 2016 Aug.

Article in Zh | MEDLINE | ID: mdl-28920333

Subject(s)

Coumarins/chemistry; Hydrolyzable Tannins/chemistry; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Inflammation; Intestines/microbiology; Male; Prostatic Neoplasms

Key words

biological activity; distribution; metabolite; urolithins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Coumarins / Hydrolyzable Tannins Limits: Female / Humans / Male Language: Zh Journal: Zhongguo Zhong Yao Za Zhi Journal subject: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Year: 2016 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google